Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-center, Prospective Randomized Controlled Study of Microwave Spherical Ablation and Traditional Microwave Ablation in the Treatment of Single Hepatocellular Carcinoma With a Diameter of ≤5cm

NCT05361538 is registered in ClinicalTrials.gov with Tianjin Third Central Hospital as lead sponsor.

NCT NCT05361538
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05361538 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-center, Prospective Randomized Controlled Study of Microwave Spherical Ablation and Traditional Microwave Ablation in the Treatment of Single Hepatocellular Carcinoma With a Diameter of ≤5cm
Lead sponsor
Tianjin Third Central Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
June 22, 2022
Completion date
June 1, 2025
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular cancer, microwave ablation, microwave spherical ablation, prognosis